MARKET PULSE-Endo Health, Orbitz, GT Advanced, Cytori, Keryx, Polypore
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; the Morning Call newsletter, r.reuters.com/vut44v) U.S. stocks drifted down to session lows on Tuesday in the wake of data showing U.S. service-sector business activity picked up in October and firms took on workers despite a partial government shutdown. The Dow Jones industrial average was down 0.58 percent, the S&P 500 was down 0.54 percent and the Nasdaq Composite was down 0.5 percent.
** ENDO HEALTH SOLUTIONS INC, $55.35, up 27 pct (10:05 a.m. ET)
The U.S.-based specialty pharmaceutical company said it would buy Canadian peer Paladin Labs Inc for about $1.6 billion to expand its presence in Canada and emerging markets.
** ORBITZ WORLDWIDE INC, $7.65, down 20 pct (9:41 a.m. ET)
The online travel agency posted quarterly earnings that missed forecasts as costs rose. The company, which operates Orbitz and CheapTickets brands in the United States and ebookers in Europe, pared its revenue forecast for 2013.
** GT ADVANCED TECHNOLOGIES INC, $10.00, up 19 pct (10:07 a.m. ET)
** RUBICON TECHNOLOGY, $10.66, up 21 pct Continued...